Long-term apremilast demonstrates continued efficacy in patients with psoriatic arthritis
New data presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism show that apremilast administered to patients with psoriatic arthritis continues to demonstrate meaningful clinical responses ...
Jun 12, 2013
0
0